Improving vaccine equity by increasing vaccine thermostability.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39047118.
- Also identified by DOI 10.1126/scitranslmed.adm7471.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development, manufacture, and deployment of new vaccine technologies to combat SARS-CoV-2 enabled an unparalleled rapid response to the emerging health threat. However, the unequal global distribution of these vaccines highlighted a major gap in existing thermotolerance profiles and cold chain infrastructure that needs to be addressed to maximize their global health impact.
Medical subject headings
- COVID-19 Vaccines
- COVID-19
- SARS-CoV-2